Many predictive and prognostic markers have been assessed in NSCLC but, until the discovery of the importance of Epidermal Growth Factor Receptor gene (EGFR) [18], no single molecular marker had proven to be useful for either patient selection or selection of specific drugs. Here, EGFR is linked to non-small cell lung carcinoma.